3D Global Biotech Inc. (TPEX:6808)
Taiwan · Delayed Price · Currency is TWD 47.25
-1.25 (-2.58%)
Oct 31, 2025, 1:35 PM CST
3D Global Biotech Market Cap
3D Global Biotech has a market cap or net worth of 3.66 billion as of October 31, 2025. Its market cap has increased by 14.76% in one year.
Market Cap
3.66B
Enterprise Value
2.98B
Revenue
324.87M
Ranking
n/a
PE Ratio
27.55
Stock Price
47.25
Market Cap Chart
Since December 25, 2020, 3D Global Biotech's market cap has increased from 2.74B to 3.66B, an increase of 33.84%. That is a compound annual growth rate of 6.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 3.66B | -28.62% |
| Dec 31, 2024 | 5.13B | 371.49% |
| Dec 29, 2023 | 1.09B | -27.35% |
| Dec 30, 2022 | 1.50B | -30.09% |
| Dec 30, 2021 | 2.14B | -18.98% |
| Dec 31, 2020 | 2.64B | -3.35% |
| Dec 25, 2020 | 2.74B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |